🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Prospective trial operable sacral chordoma Similar outcomes Carbon vs. Surgery

Surprised in Vienna—just as I visited Belvedere Palace, I learned I received the Mayo Clinic Distinguished Early Career Alumnus Award (within 15 yrs of starting the profession). Grateful for 15 years of support, friendship & family. Honored and motivated to keep going!

How we "guessed" the Pope using network science: inside the cardinal network. A study by me, Beppe Soda and Alessandro Iorio. Article: unibocconi.it/en/news/networ… Università Bocconi

Reclassifying each N category 1 stratum higher for imaging-detected extranodal extension-positive disease resulted in better disease-free and overall survival in patients human papillomavirus–positive oropharyngeal carcinoma. ja.ma/4k0TANm Melvin LK CHUA | FRCR, PhD, FASCO

Some news: At the end of the month, I will be leaving the NCI after nearly 9 years... 🧵 1/5

Humbled and happy as well that Mayo Clinic Comprehensive Cancer Center was a part of this important work as well! David Routman Katie Van Abel (she/her(s))

Mayo Clinic is pleased to welcome micky tripathi, Ph.D. as Chief Artificial Intelligence Implementation Officer. Dr. Tripathi’s extensive healthcare leadership experience will help us accelerate our Bold. Forward. strategy to transform healthcare.

🚨 NEOPAN - Pancreatic Cancer Update 🚨 In LAPC (locally advanced pancreatic cancer) 🧬: 📊 Trial compared FOLFIRINOX vs Gemcitabine 👥 171 patients, PS ≤1, unresectable cases 📌 Primary endpoint: PFS 📌 Secondary endpoints: OS, QoL, safety 🧪 Results: 🕒 Median PFS: ➡️

Wow, this trial showed no OS benefit to FOLFIRINOX vs. single agent gemcitabine in locally advanced pancreas cancer (different than adjuvant & metastatic trials - both w OS improvement!) PFS increased by 2 mo, but this came at cost of increased toxicity, $, treatment burden.

We're barely 2 years from Will Smith eating spaghetti...

I had to try this prompt with a slight modification. I can’t believe this works. Google Flow Veo3. Prompt: a man with dad bod doing stand up comedy in a small venue tells a dad joke (include the joke in the dialogue)

AI video is moving faster than anyone really anticipated. Anything can be generated.

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Great game today — Go Wolves!!! Kenneth Olivier

Training to be a doctor accelerates cellular aging. Telomeres shrank 6x faster in one study (worse with more hours). After 100-hour weeks and a peak of nine 26-hour shifts in a month, I’m banking on exercise and healthy habits to save me.

Detection of cancers three years prior to diagnosis using plasma cell-free DNA aacrjournals.org/cancerdiscover…

Truly inspired to hear the clinical chair of RadComp Dr. Shannon MacDonald Shannon M MacDonald present in the PTCOG-ASTRO plenary session at #PTCOG63. ✅ Accrual complete — 1,238 patients 💙 A landmark trial in breast cancer radiation 👏 Incredible commitment from the team to

First phase III randomized study showed an improvement in overall survival with proton-based IMPT compared to photon IMRT in head and neck cancer. This was presented today during the The Particle Therapy Co-Operative Group (PTCOG) plenary session by Steven J. Frank, MD. The exciting data provides justification for IMPT.

Very happy to share our new paper on LLM-based tumor board agents. Submitted August 2024, published in Nature Cancer today ☺️ Led by Dyke Ferber nature.com/articles/s4301…

SACRAL CHORDOMA: Particle RT vs. Surgery Prospective SACRO Study Presented by Dr. Fossati No significant differences in PFS, OS, or local/distant failure. Although patients receiving RT had worse tumor locations, they showed numerically better outcome and lower toxicity.